BR102018071330A2 - water treatment composition - Google Patents

water treatment composition Download PDF

Info

Publication number
BR102018071330A2
BR102018071330A2 BR102018071330A BR102018071330A BR102018071330A2 BR 102018071330 A2 BR102018071330 A2 BR 102018071330A2 BR 102018071330 A BR102018071330 A BR 102018071330A BR 102018071330 A BR102018071330 A BR 102018071330A BR 102018071330 A2 BR102018071330 A2 BR 102018071330A2
Authority
BR
Brazil
Prior art keywords
water treatment
treatment composition
support
organic compound
treatment component
Prior art date
Application number
BR102018071330A
Other languages
Portuguese (pt)
Inventor
Peter Morgan Robert
Original Assignee
Marine Easy Clean Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marine Easy Clean Pty Ltd filed Critical Marine Easy Clean Pty Ltd
Priority to BR102018071330A priority Critical patent/BR102018071330A2/en
Publication of BR102018071330A2 publication Critical patent/BR102018071330A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/52Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/54Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
    • C02F1/56Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00Nature of the contaminant
    • C02F2101/10Inorganic compounds
    • C02F2101/20Heavy metals or heavy metal compounds
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/08Seawater, e.g. for desalination
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/20Nature of the water, waste water, sewage or sludge to be treated from animal husbandry

Abstract

uma composição para o tratamento da água compreendendo um componente de tratamento e um suporte em que o componente de tratamento é um composto orgânico líquido, e o suporte é um composto orgânico sólido.a water treatment composition comprising a treatment component and a support in which the treatment component is a liquid organic compound, and the support is a solid organic compound.

BR102018071330A 2018-10-17 2018-10-17 water treatment composition BR102018071330A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR102018071330A BR102018071330A2 (en) 2018-10-17 2018-10-17 water treatment composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102018071330A BR102018071330A2 (en) 2018-10-17 2018-10-17 water treatment composition

Publications (1)

Publication Number Publication Date
BR102018071330A2 true BR102018071330A2 (en) 2020-04-28

Family

ID=70547268

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102018071330A BR102018071330A2 (en) 2018-10-17 2018-10-17 water treatment composition

Country Status (1)

Country Link
BR (1) BR102018071330A2 (en)

Similar Documents

Publication Publication Date Title
BR112018004620A2 (en) kras expression modulators
CL2018003135A1 (en) Aromatic derivatives of sulfonamide.
BR112018073329A2 (en) combination, pharmaceutical composition, kit, method for treating cancer, method for reducing a cell level, method for increasing activity, method for increasing cytotoxicity, method for reducing metastasis
CL2018000542A1 (en) New phenoxymethyl derivatives.
CO2017013065A2 (en) Diaciglycerol acyltransferase 2 modulators (dgat2)
CL2012003415A1 (en) Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
ECSP21026021A (en) PNPLA3 EXPRESSION MODULATORS
CL2008000202A1 (en) Compounds derived from n-aryl-acetamide, trpv1 antagonist, pharmaceutical composition that comprises them, useful in the treatment of pain.
CL2015000976A1 (en) Compounds of 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine for use in the treatment of diabetes and its associated disorders.
CL2016003074A1 (en) Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.
CL2016002497A1 (en) "Compounds derived from substituted condensed heterocycles, modulators of gpr119; pharmaceutical composition comprising them; useful in the treatment of diabetes, obesity, dyslipidemia and related disorders ”. pct
CL2016002151A1 (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
CR20190471A (en) Modulators of pcsk9 expression
CL2017002214A1 (en) Combination formulation of tesofensin and beta blocker
AR108148A1 (en) METHODS TO COVER PACKING SURFACES WITH BENZOXABOROL COMPOUNDS TO PRESERVE FOOD FRESH
CL2015002113A1 (en) Azetidinloxyphenylpyrrolidine compounds
BRPI0810762A8 (en) COMPOSITION FOR WATER TREATMENT
CL2021001246A1 (en) Irf5 expression modulators.
CO2020008769A2 (en) Modulators of the dnm2 expression
UY38472A (en) FOXP3 EXPRESSION MODULATORS
CO2020003134A2 (en) Modulators of enac expression
CO2017001076A2 (en) Antihyperalgesic, anti-allodinic and anti-inflammatory pharmaceutical compositions containing pregabalin and meloxicam
BR102018071330A2 (en) water treatment composition
CU20170134A7 (en) 2-THIOPIRIMIDINONES
BR112017001375A2 (en) pharmaceutical agent

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]